KG
AZN icon

Kilter Group’s AstraZeneca AZN Stock Holding History

Kilter Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5K Buy
108
+100
+1,250% +$18.8K 0.01% 284
2026
Q1 		$1.58K Sell
8
-22
-73% -$4.24K ﹤0.01% 1044
2025
Q4 		$5.42K Buy
30
+17
+131% +$2.98K ﹤0.01% 493
2025
Q3 		$2K Buy
13
+4
+44% +$605 ﹤0.01% 660
2025
Q2 		$1.19K Buy
+9
New +$1.26K ﹤0.01% 775

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kilter Group's AZN Position: Q2 2026 in Review

Kilter Group increased its AstraZeneca (AZN) stake by 1,250% in Q2 2026, buying an estimated $18.8K and bringing the position to 108 shares worth $20.5K. The position accounts for 0.01% of the portfolio, ranked #284.

Kilter Group first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Kilter Group held 108 shares of AstraZeneca worth $20.5K as of Q2 2026.
  • Kilter Group bought 100 AstraZeneca shares in Q2 2026, an estimated $18.8K.
  • AstraZeneca made up 0.01% of Kilter Group's portfolio in Q2 2026, its #284 holding.
  • Kilter Group first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.